The Financial Time’s, Global Pharmaceutical and Biotechnology Conference, starts today (9th—11th November) 11.30am GMT, 6.30am EST.

Volt are proud to be the only workforce solutions provider sponsoring this event, joining other leading global companies such as; Deloitte, Amazon, Icon, Cytiva, Livongo, Medidata, Samsung Bioepis, Veeva and Tracelink.

World-class business leaders and speakers include: Teresa Graham, Head of Global Product Strategy - Roche Pharma, Paul Hudson
CEO - Sanofi, Roger Connor, President Global Vaccines - GSK, Anthony Fauci, US Director -
National Institute of Allergy and Infectious Disease, Bertrand Bodson, Chief Digital Officer - Novartis, Kenneth Hillan, Head of Therapeutics - 23andMe, Samarth Kulkarni, CEO - CRISPR Therapeutics, share their insights and expertise on topics to include the increasingly complex and uncertain political and pricing environment, re-shaping the pharma pipeline for growth and the coronavirus pandemic as a 21st century case study of pharma and health.

The Financial Times is one of the world’s leading news organisations, recognized internationally for its authority, integrity and accuracy. It is part of Nikkei Inc., which provides a broad range of information, news and services for the global business community.

FT Event details: https://lnkd.in/gbaw8jE

Volt won the Global Healthcare and Pharmaceutical Workforce Provider of the year 2020 - find out what our Life Sciences offer: https://www.voltinternational.com/disciplines/life-sciences